[HTML][HTML] Ketogenic diets and chronic disease: weighing the benefits against the risks

L Crosby, B Davis, S Joshi, M Jardine, J Paul… - Frontiers in …, 2021 - frontiersin.org
Very-low-carbohydrate ketogenic diets have been long been used to reduce seizure
frequency and more recently have been promoted for a variety of health conditions …

[HTML][HTML] Low-carb and ketogenic diets in type 1 and type 2 diabetes

AM Bolla, A Caretto, A Laurenzi, M Scavini, L Piemonti - Nutrients, 2019 - mdpi.com
Low-carb and ketogenic diets are popular among clinicians and patients, but the
appropriateness of reducing carbohydrates intake in obese patients and in patients with …

Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical …

SJ Athinarayanan, RN Adams, SJ Hallberg… - Frontiers in …, 2019 - frontiersin.org
Purpose: Studies on long-term sustainability of low-carbohydrate approaches to treat
diabetes are limited. We previously reported the effectiveness of a novel digitally-monitored …

Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis

EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng… - Gut, 2023 - gut.bmj.com
Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease

A Fougerat, A Montagner, N Loiseau, H Guillou… - Cells, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …

Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)

HK Drescher, S Weiskirchen, R Weiskirchen - Cells, 2019 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
Western countries with almost 25% affected adults worldwide. The growing public health …

Low-Carbohydrate diets in the management of obesity and type 2 diabetes: a review from clinicians using the approach in practice

T Kelly, D Unwin, F Finucane - International journal of environmental …, 2020 - mdpi.com
Low-carbohydrate diets are increasingly used to help patients with obesity and type 2
diabetes. We sought to provide an overview of the evidence for this treatment approach …

Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma

M Kosmalski, A Śliwińska, J Drzewoski - Biomedicines, 2023 - mdpi.com
In clinical practice, we often deal with patients who suffer from non-alcoholic fatty liver
disease (NAFLD) concurrent with type 2 diabetes mellitus (T2DM). The etiopathogenesis of …

[HTML][HTML] Digital twin-enabled personalized nutrition improves metabolic dysfunction-associated fatty liver disease in type 2 diabetes: results of a 1-year randomized …

S Joshi, P Shamanna, M Dharmalingam, A Vadavi… - Endocrine Practice, 2023 - Elsevier
Objective Postprandial hyperglycemia drives insulin resistance and inflammation, leading to
metabolic dysfunction-associated fatty liver disease (MAFLD). Prediction of postprandial …

Protein and amino acids in nonalcoholic fatty liver disease

D Tricò, E Biancalana, A Solini - Current Opinion in Clinical …, 2021 - journals.lww.com
Mechanistic studies in NAFLD have been mostly focused on carbohydrate and fat
metabolism, while little is known about the influence of protein and amino acids. Moreover …